510(k) Report

510(k) · Cleared

Cleared

ALBG

K981468510(k) TraditionalCleared May 27, 199834-day reviewClass II21 CFR 862.1035

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Laboratories · CIX Bromcresol Green Dye-Binding, Albumin

Cleared on May 27, 1998 as substantially equivalent to K811194 (Boehringer Mannheim Corp., 1981) after a 34-day review. Its family tree reaches back 1 generation to 1981.

Decided
May 27, 1998
Review
34 days
Class
Class II
Product code
CIX
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K811194 (1981). No later device cites it as a predicate yet.

K811194 · Hitachi 705 Automatic Blood Chemistry · Boehringer Mannheim Corp. · 198119801985199019952000
  1. Root · 1 generation backK811194 Hitachi 705 Automatic Blood ChemistryBoehringer Mannheim Corp. · 1981
  2. This deviceK981468 ALBGAbbott Laboratories · 1998
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K811194Hitachi 705 Automatic Blood ChemistryBoehringer Mannheim Corp.1981—
0 (this device)K981468ALBGAbbott Laboratories1998—
FIG. 1 — Lineage of K981468, 1981–1998Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CIX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CIX device

  1. #1 K251157 Core Metabolicscore 11.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K811194Hitachi 705 Automatic Blood Chemistry
Summary page 1
…to the albumin concentration in the sample. Substantial Equivalence: The Albumin BCG assay is substantially equivalent to the Boehringer Mannheim® Albumin BCG assay (K811194) on the Hitachi® 717 Analyzer. This assay yields similar Performance Characteristics. Albumin BCG 510(k) Section II April 22, 1…
Boehringer Mannheim Corp.1981—

Also cleared against K811194: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 4 other devices also cite its predicate K811194.

How does its category compare?

All CIX devices

CIX Bromcresol Green Dye-Binding, Albumin: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CIX

2in 2021

2007: 12008: 12009: 12011: 32012: 12013: 12018: 12019: 12021: 22026 (partial year): 1
2007high 3 (2011) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CIX

168in 2011

2011: 168 days median
2007high 168 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CIX

1in 2020

2008: 12010: 12013: 12019: 12020: 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CIX

4in 2025

2007: 12010: 742011: 82012: 22016: 12017: 62018: 22020: 12021: 32022: 12023: 42024: 32025: 4
2007high 74 (2010) · low 0 (2008)2025

MAUDE reports naming product code CIX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—01
20081—10
20091—00
20100—174
2011316808
20121—02
20131—10
20140—00
20150—00
20160—01
20170—06
20181—02
20191—10
20200—11
20212—03
20220—01
20230—04
20240—03
20250—04
20261—0—

What is it indicated for?

The Albumin BCG assay is used for the quantitation of albumin in serum. Albumin measurements are used in the diagnosis and treatment of numerous diseases involving primarily the liver or kidneys.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K981468: ALBG.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K981468

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026